Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. - Test2 - elhamkhani - TriplyDB

Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.

Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.

http://www.wikidata.org/entity/Q33957072

about

Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery Inorganic Janus particles for biomedical applications Carbon dioxide hydrogenation to aromatic hydrocarbons by using an iron/iron oxide nanocatalyst Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes.Compact zwitterion-coated iron oxide nanoparticles for in vitro and in vivo imaging.Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide: long-circulating nanoparticles for in vivo multimodal (T1 MRI-SPECT) imaging.Developing Fe3O4 nanoparticles into an efficient multimodality imaging and therapeutic probe.One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging.Multifunctional PEGylated multiwalled carbon nanotubes for enhanced blood pool and tumor MR imaging.One-step, room-temperature synthesis of glutathione-capped iron-oxide nanoparticles and their application in in vivo T1-weighted magnetic resonance imaging.Facile non-hydrothermal synthesis of oligosaccharides coated sub-5 nm magnetic iron oxide nanoparticles with dual MRI contrast enhancement effect.Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging Color Tunable Gd-Zn-Cu-In-S/ZnS Quantum Dots for Dual Modality Magnetic Resonance and Fluorescence Imaging.One-step synthesis of degradable T(1)-FeOOH functionalized hollow mesoporous silica nanocomposites from mesoporous silica spheres.An aqueous method for the controlled manganese (Mn(2+)) substitution in superparamagnetic iron oxide nanoparticles for contrast enhancement in MRI.RGD-functionalized ultrasmall iron oxide nanoparticles for targeted T₁-weighted MR imaging of gliomas.Geometrically confined ultrasmall gadolinium oxide nanoparticles boost the T(1) contrast ability.Green Synthesis of Sub-10 nm Gadolinium-Based Nanoparticles for Sparkling Kidneys, Tumor, and Angiogenesis of Tumor-Bearing Mice in Magnetic Resonance Imaging.Enhanced MRI T 2 Relaxivity in Contrast-Probed Anchor-Free PEGylated Iron Oxide Nanoparticles.Magnetic sensing technology for molecular analyses Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.Superparamagnetic iron oxide nanoparticles with variable size and an iron oxidation state as prospective imaging agents A targeted approach to cancer imaging and therapy Design of a modular protein-based MRI contrast agent for targeted application.Hybrid nanotrimers for dual T1 and T2-weighted magnetic resonance imaging Uniform iron oxide hollow spheres for high-performance delivery of insoluble anticancer drugs.Screen-based analysis of magnetic nanoparticle libraries formed using peptidic iron oxide ligands Biocompatible PEGylated Fe₃O₄ nanoparticles as photothermal agents for near-infrared light modulated cancer therapy.L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.Interplay between longitudinal and transverse contrasts in Fe3O4 nanoplates with (111) exposed surfaces Coordination-Induced Assembly of Intelligent Polysaccharide-Based Phototherapeutic Nanoparticles for Cancer Treatment.Radiofrequency heating pathways for gold nanoparticles.Magnetic Nanoparticles: Material Engineering and Emerging Applications in Lithography and Biomedicine.In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles Fabricating Water Dispersible Superparamagnetic Iron Oxide Nanoparticles for Biomedical Applications through Ligand Exchange and Direct Conjugation.Personalized nanomedicine advancements for stem cell tracking.A synergistically enhanced T(1) -T(2) dual-modal contrast agent.Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging.Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging Active-target T1-weighted MR Imaging of Tiny Hepatic Tumor via RGD Modified Ultra-small Fe3O4 Nanoprobes.

P2860

Q26830434-CD6D7FD0-73FA-47BC-B3CD-673BE42640F6 Q28085653-42837087-B657-459D-98BF-CA2C9B3902E9 Q28656448-B816EF7E-6CB4-4C4E-8B3A-E4B7EA6D0050 Q30564493-A59ADC16-A60D-45D8-8536-563B3E2D2E87 Q30572304-5EA2BF85-10A6-4AFA-AF94-DC3521EE0ADB Q30578977-62AF6F90-22F1-4B26-89D9-667661405604 Q30678695-4AB274B8-A051-4CFA-ACFF-1855CE8776CA Q30746227-9E652B75-3B87-4D3D-928C-EE8B8F59FC65 Q30785098-A6EFCD55-C5C8-48A2-8CDA-B932AA6E44BD Q30837537-FDCA7D94-50B3-42BC-AA7C-16C1E4227371 Q30847182-3510AACF-2E76-4094-82E6-F20E9D0D3C52 Q30851553-26E46F9C-BB3E-4589-BB34-7C424D0C06E2 Q30875682-4F195064-1A61-4EEE-839D-4D6936253AC5 Q30884179-E8D3250D-37E4-4DA6-B51A-699B44080DA1 Q30884375-D4DA2C1A-4DCB-4B52-BFE7-D7D880C315CA Q30986321-588B347C-C0DA-45CF-B8CA-EF19E1D168AE Q31040215-11AFE2D7-FB92-4D22-A4A8-0A6ECEF1681B Q31150647-EDD9365F-EBD2-4473-8880-1E0C2F81154B Q33609943-79B92AEB-68B2-472D-94C3-9651923528C2 Q33901900-5821C790-7A68-441B-86A1-D378645788B3 Q34138469-985EDF72-AA23-47CB-A9DD-A0C75B2A99BD Q34515005-24BD1F00-9112-49D4-94A0-97BD665A1870 Q34523300-65EB267D-B3E8-49C2-9965-9496B8D6A9E9 Q34769835-F86B0250-6CE5-45C4-96DF-5EDC1017AB47 Q35100728-FF29B9AD-F410-4FA9-9AE9-9776168B77B5 Q35137690-BFDB4F4E-D5FE-4C6D-9813-9823CE83D85A Q35232139-3F95688A-0C55-4B28-A41E-413DFF756C78 Q35348651-D1694FF7-AA91-424B-9416-4C20A491A55F Q35855865-14AA7B23-C1F4-4163-8DA6-A5E7003E1E84 Q36057302-6918301E-D666-442D-AC73-AA6243889291 Q36196857-5FD35922-E045-420C-8115-070216FEC0BB Q36219041-509F870F-9150-4983-B5CE-0034974F05B6 Q36283461-154C4D5F-F51E-40D0-9FC5-271299468674 Q36289257-66B0AE8D-67ED-46BD-A681-B6AF73628C83 Q36320627-1210239E-EB9B-407A-8356-D2A5EAD3F0BA Q36335838-D3F6653C-381F-426C-AA4E-D3BDE4DD0D2E Q36790059-2A5F5F0C-5473-424E-80F4-E17581482A51 Q36854172-04A81ABF-A5F7-473C-9C17-42C60339B5CA Q37014204-59F7000B-2D51-4317-90A7-E4CB5D12483F Q37202282-A2EE5FAA-092A-4298-9D74-75BF30C9CECA

P2860

Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.

http://www.wikidata.org/entity/Q33957072

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Large-scale synthesis of unifo ...... nance imaging contrast agents.

@ast

Large-scale synthesis of unifo ...... nance imaging contrast agents.

@en

type

label

Large-scale synthesis of unifo ...... nance imaging contrast agents.

@ast

Large-scale synthesis of unifo ...... nance imaging contrast agents.

@en

prefLabel

Large-scale synthesis of unifo ...... nance imaging contrast agents.

@ast

Large-scale synthesis of unifo ...... nance imaging contrast agents.

@en

P1433

Q33957072-DF281E71-F972-49D0-8608-5EE61FEE2A7E

P1476

Q33957072-6C7C2F1F-968B-4C75-B632-5039DF35D7E8

P2093

Q33957072-0198C00B-EC87-48FB-9F47-09A2D32EEBCA

Q33957072-164F6746-F6C8-432D-AEB1-A59E407605D5

Q33957072-1DD4DC5F-F6AE-4D00-90FA-673D5A6F4A12

Q33957072-4222E211-2960-43A5-908B-D2EECB6F09D1

Q33957072-4A3A3169-19E5-4494-B5F6-27500C3EE731

Q33957072-52CDF6FD-566C-4EFF-9615-CD7C30CB1230

Q33957072-5C1B6486-94F2-4634-9AAB-D5F7AB89814D

Q33957072-83D827D5-920E-4D25-8A11-B32FD293573D

Q33957072-9CA8E76F-C6F7-4410-8A36-471176EE2663

Q33957072-A50CEB61-C273-40E4-AF72-5E4FFBD62CF5

P304

Q33957072-0A02D48B-B81A-4D15-8DCC-214ECB0605F6

P31

Q33957072-372FF03E-6E9C-457C-AA71-D19E42510924

P356

Q33957072-F3DE1DAC-27E5-46C0-974C-A1ADE77434CB

P407

Q33957072-17584A7E-AE77-4D6D-A1A4-CF34CA5807C9

P433

Q33957072-00FBD3D4-C3E7-4659-96C7-306F071B3C03

P478

Q33957072-4B969B66-968D-4CFB-AE0D-A0C5A0A44129

P50

Q33957072-035D6214-5BB1-4BAD-ADD2-9F94CC89FFF2

Q33957072-D39EFDFE-EC64-40FE-96E6-739471CA962A

Q33957072-E81F4D2F-9C4C-428A-8C0C-5D71AD98FAA0

P577

Q33957072-1E3DF99D-8C58-4981-B96E-354DCD09C0FD

P5875

Q33957072-4430EB51-4794-4DAA-BF39-9867B06012AC

P698

Q33957072-D610E6D7-DF2A-470D-9E1D-6F675FF8E88D

P921

Q33957072-39C3F683-E924-496A-8B18-63DE60967222

Q33957072-9BD09BA6-A3E5-4453-B55C-4F0F825CB1FF

P356

P1433

Journal of the American Chemical Society

P1476

Large-scale synthesis of unifo ...... nance imaging contrast agents.

@en

P2093

Byung Hyo Kim

http://www.w3.org/2001/XMLSchema#string

Hyoungsu Kim

http://www.w3.org/2001/XMLSchema#string

Je-Geun Park

http://www.w3.org/2001/XMLSchema#string

Kwangjin An

http://www.w3.org/2001/XMLSchema#string

Kwangsoo Shin

http://www.w3.org/2001/XMLSchema#string

Nohyun Lee

http://www.w3.org/2001/XMLSchema#string

Tae-Young Ahn

http://www.w3.org/2001/XMLSchema#string

Taeghwan Hyeon

http://www.w3.org/2001/XMLSchema#string

Woo Kyung Moon

http://www.w3.org/2001/XMLSchema#string

Yong Il Park

http://www.w3.org/2001/XMLSchema#string

P304

12624-12631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JA203340U

http://www.w3.org/2001/XMLSchema#string

P407

P433

32

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

Seung Hong Choi

P577

2011-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51482309

http://www.w3.org/2001/XMLSchema#string

P698

21744804

http://www.w3.org/2001/XMLSchema#string

P921

magnetic nanoparticles